Geneos Wealth Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Geneos Wealth Management’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-357	Closed	-$7K	–	2131
2022 Q3	$7K	Hold	357	–	–	﹤0.01%	1637
2022 Q2	$7K	Hold	357	–	–	﹤0.01%	2110
2022 Q1	$5K	Hold	357	–	–	﹤0.01%	2377
2021 Q4	$7K	Hold	357	–	–	﹤0.01%	2326
2021 Q3	$6K	Hold	357	–	–	﹤0.01%	2423
2021 Q2	$9K	Hold	357	–	–	﹤0.01%	2259
2021 Q1	$10K	Hold	357	–	–	﹤0.01%	2401
2020 Q4	$10K	Hold	357	–	–	﹤0.01%	2236
2020 Q3	$8K	Hold	357	–	–	﹤0.01%	2050
2020 Q2	$6K	Hold	357	–	–	﹤0.01%	2118
2020 Q1	$2K	Hold	357	–	–	﹤0.01%	2320
2019 Q4	$4K	Hold	357	–	–	﹤0.01%	2272
2019 Q3	$4K	Hold	357	–	–	﹤0.01%	2193
2019 Q2	$8K	Sell	357 -15	-4%	-$432	﹤0.01%	2001
2019 Q1	$11K	Buy	+372	New	+$13.2K	﹤0.01%	1820

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geneos Wealth Management's CVET Position: Q4 2022 in Review

Geneos Wealth Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 357 shares — an estimated $7K sold.

Geneos Wealth Management first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $11K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Geneos Wealth Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Geneos Wealth Management sold 357 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $7K.
Geneos Wealth Management first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
Geneos Wealth Management's Covetrus, Inc. Common Stock position peaked at $11K in Q1 2019.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.